Slingshot members are tracking this event:

Aimmune's (AIMT) AR101 Peanut Allergy Phase 3 data to be presented February 24 at AAAAI Annual Meeting.

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
AIMT Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Ar101, Peanut Allergy, Phase 3 Study, Aaaai Annual Meeting